2013;112:1943 7. S2.3-6. Khairy P, Aboulhosn J, Gurvitz MZ, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122:868 75. S2.3-7. Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrilla- tors in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1:250 7. S2.3-8. Inuzuka R, Diller G-P, Borgia F, et al. Comprehensive use of cardi- opulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250 9. S2.3-9. M ller J, Hager A, Diller G-P, et al. Peak oxygen uptake, venti- latory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot. Int J Cardiol. 2015;196:158 64. S2.3-10. Stefanescu A, Macklin EA, Lin E, et al. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. Am J Cardiol. 2014;113:865 70. S2.3-11. Giannakoulas G, Dimopoulos K, Engel R, et al. Burden of coronary artery disease in adults with congenital heart disease and its rela- tion to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445 50. S2.3-12. Giannakoulas G, Dimopoulos K, Bolger AP, et al. Usefulness of na- triuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol. 2010;105:869 73. S2.3-13. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85 92. S2.3-14. Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defi- brillators in tetralogy of Fallot. Circulation. 2008;117:363 70. CLINICAL STATEMENTS AND GUIDELINES S2.3-15. Dimopoulos K, Diller G-P, Giannakoulas G, et al. Anemia in adults with congenital heart disease relates to adverse outcome. 